FI792080A - Framstaellning av nya fenetanolaminer - Google Patents

Framstaellning av nya fenetanolaminer

Info

Publication number
FI792080A
FI792080A FI792080A FI792080A FI792080A FI 792080 A FI792080 A FI 792080A FI 792080 A FI792080 A FI 792080A FI 792080 A FI792080 A FI 792080A FI 792080 A FI792080 A FI 792080A
Authority
FI
Finland
Prior art keywords
phenethanolaminer
nya
framstaellning
nya phenethanolaminer
Prior art date
Application number
FI792080A
Other languages
English (en)
Other versions
FI67686C (fi
FI67686B (fi
Inventor
Jack Mills
Klaus Kurt Schmiegel
Richard Eugene Toomey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI792080A publication Critical patent/FI792080A/fi
Application granted granted Critical
Publication of FI67686B publication Critical patent/FI67686B/fi
Publication of FI67686C publication Critical patent/FI67686C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI792080A 1978-07-03 1979-07-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat FI67686C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03
US92166878 1978-07-03

Publications (3)

Publication Number Publication Date
FI792080A true FI792080A (fi) 1980-01-04
FI67686B FI67686B (fi) 1985-01-31
FI67686C FI67686C (fi) 1985-05-10

Family

ID=25445786

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792080A FI67686C (fi) 1978-07-03 1979-07-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat

Country Status (33)

Country Link
EP (2) EP0007206B1 (fi)
JP (1) JPS559100A (fi)
AR (2) AR222658A1 (fi)
AT (1) AT370408B (fi)
AU (1) AU521744B2 (fi)
BE (1) BE877392A (fi)
BG (3) BG40482A3 (fi)
CA (1) CA1120058A (fi)
CH (1) CH641759A5 (fi)
CS (2) CS208661B2 (fi)
DD (1) DD144763A5 (fi)
DK (1) DK268579A (fi)
EG (1) EG14400A (fi)
ES (2) ES482153A1 (fi)
FI (1) FI67686C (fi)
FR (1) FR2430409A1 (fi)
GB (1) GB2028800B (fi)
GR (1) GR72546B (fi)
HK (1) HK44087A (fi)
HU (1) HU179170B (fi)
IE (1) IE48436B1 (fi)
IL (1) IL57670A (fi)
LU (1) LU81456A1 (fi)
MX (1) MX6160E (fi)
MY (1) MY8500596A (fi)
NZ (1) NZ190859A (fi)
PH (1) PH15650A (fi)
PL (2) PL123990B1 (fi)
PT (1) PT69840A (fi)
RO (2) RO83053B (fi)
SU (2) SU965351A3 (fi)
YU (1) YU154879A (fi)
ZA (1) ZA793295B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (en) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
PH20912A (en) * 1983-01-31 1987-05-28 Lilly Co Eli -phenethanolamine derivatives useful for promoting the growth, improving the efficiency of feed utilization and improving the leanless of domesticated animals
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β-拟肾上腺素***型饲料添加剂的合成方法
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (fi) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
AU4848879A (en) 1980-01-10
GR72546B (fi) 1983-11-17
FR2430409A1 (fr) 1980-02-01
GB2028800A (en) 1980-03-12
BG40481A3 (en) 1986-12-15
BE877392A (fr) 1980-01-02
SU965351A3 (ru) 1982-10-07
FI67686C (fi) 1985-05-10
RO77731A (ro) 1981-11-24
BG40482A3 (en) 1986-12-15
CH641759A5 (fr) 1984-03-15
ES8101537A1 (es) 1980-12-16
FR2430409B1 (fi) 1981-05-29
EP0047536A2 (en) 1982-03-17
CA1120058A (en) 1982-03-16
EP0047536A3 (en) 1982-03-24
DK268579A (da) 1980-01-04
AT370408B (de) 1983-03-25
PL222867A1 (fi) 1981-01-02
EG14400A (en) 1983-12-31
JPS636058B2 (fi) 1988-02-08
BG40480A3 (en) 1986-12-15
AU521744B2 (en) 1982-04-29
HK44087A (en) 1987-06-12
ATA463979A (de) 1982-08-15
GB2028800B (en) 1982-11-03
LU81456A1 (fr) 1979-10-30
PL119783B1 (en) 1982-01-30
IE48436B1 (en) 1985-01-23
EP0007206B1 (en) 1983-02-23
JPS559100A (en) 1980-01-22
EP0047536B1 (en) 1984-06-27
SU931102A3 (ru) 1982-05-23
DD144763A5 (de) 1980-11-05
FI67686B (fi) 1985-01-31
HU179170B (en) 1982-08-28
AR222658A1 (es) 1981-06-15
RO83053A (ro) 1984-02-21
ZA793295B (en) 1981-02-25
MY8500596A (en) 1985-12-31
IL57670A (en) 1982-11-30
PL123990B1 (en) 1982-12-31
RO83053B (ro) 1984-02-28
NZ190859A (en) 1984-09-28
ES487847A0 (es) 1980-12-16
IL57670A0 (en) 1979-10-31
IE791231L (en) 1980-01-03
EP0007206A1 (en) 1980-01-23
PL216810A1 (fi) 1980-07-28
ES482153A1 (es) 1980-08-16
AR222727A1 (es) 1981-06-15
PH15650A (en) 1983-03-11
CS208660B2 (en) 1981-09-15
MX6160E (es) 1984-11-29
YU154879A (en) 1983-04-30
CS208661B2 (en) 1981-09-15
PT69840A (en) 1979-07-01

Similar Documents

Publication Publication Date Title
FI801609A (fi) Foerfarande foer framstaellning av nya kefalosporinantibiotika
FI792082A (fi) Framstaellning av nya fenetanolaminer
FI791084A (fi) Nya n-heterocyklo-4-piperidinaminer
FI791754A (fi) Nya aminotiazoler
FI65444B (fi) Foerfarande foer framstaellning av cyklodextrin/polyvinylalkohol-polymerer vilka bildar inklusionskomplex
FI792567A (fi) Nya spiro-oxazolidinoner
FI791679A (fi) Foerfarande foer framstaellning av nya kefalosporinantibiotika
FI792080A (fi) Framstaellning av nya fenetanolaminer
FI65631B (fi) Foerfarande foer framstaellning av a-21978-antibiotika
FI791343A (fi) Nya isokinolinderivat och foerfarande foer framstaellning av dessa
FI792079A (fi) Processer foer framstaellning av nya fenetanolaminer
FI801618A (fi) Foerfarande foer framstaellning av nya penicillansyraderivat
FI800298A (fi) Foerfarande foer framstaellning av nya antracyklina derivater
SE7909023L (sv) Nya azolylketaler
FI58353B (fi) Foerfarande foer selektiv avlaegsning av foereningar fraon sulfidiska komplexmalmer blandmalmer eller -koncentrat
FI790820A (fi) Foerfarande foer framstaellning av nya n-fenylalaninderivat
FI792076A (fi) Foerfarande foer framstaellning av nya fenylpiperidinderivat
FI791210A (fi) Nya benzodioxolderivat
FI791183A (fi) Foerfarande foer framstaellning av nya oximer haerledda fraon 3-azidometyl-7-amino-tiazolyl-acetamidocefalosporansyra
FI790285A (fi) Foerfarande foer framstaellning av nya purinderivat
FI792078A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara propylaminderivat
FI793215A (fi) Nya tricykliska ortofusionerade kvaeve innehaollande foereningar
FI791439A (fi) Nya foereningar av n-cyano-azometiner
FI793181A (fi) Nya (1-aryl-cykloalkylmetyl)isotiocyanater
FI800938A (fi) Foerfarande foer framstaellning av nya ftalazinderivat

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ELI LILLY AND COMPANY